Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Concrete Relief for Vertebral Fractures

Kurt Ullman  |  Issue: April 2008  |  April 1, 2008

“The guidelines suggest the appropriate person for either of these procedures should have had a vertebral fracture with pain that has not resolved with at least two weeks of conservative treatment,” says Robin Dore, MD, clinical professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles. “It is also essential that an MRI be obtained to confirm that there is not a burst fracture present. PVA is contraindicated in that type of fracture because the cement can migrate and impinge on the spinal cord.” The most recent guidelines were published last year in the Journal of Vascular and Interventional Radiology.2

Although there have been no randomized trials comparing the two methods on outcome and efficacy, the guideline authors looked at the literature that was available on the subject. They stated, “The Societies [involved with the guidelines] have determined that the clinical response rates in individuals [treated with kyphoplasty] is equivalent to those seen in patients treated with vertebroplasty.” They also saw no proven advantage in pain relief, vertebral height, or complication rate.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Most of the complications associated with both procedures center around leakage of the PMMA. During injection, leakage of cement into the spinal canal can cause compression of the nerves or spinal cord that can lead to permanent neurologic injury even with surgical removal. Some instances of the cement entering circulation and then the lung causing an embolus have been reported. Rib fracture or pedicle fracture can occur during needle placement. Bleeding and infection are rare. Most series suggest a complication rate around 2%.

Two experts interviewed for this article still suggest caution. “One of the reasons we may not have seen a lot of ill effects is because they aren’t really being done on a routine basis yet,” says Elinor A. Mody, MD, associate physician in the division of rheumatology, immunology, and allergy at Brigham and Women’s Hospital in Boston. “As we know from recent experience with medications, the time we really find out about the downsides is when it becomes more widely used.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Smuck says that while this may have been true five years ago, more recent data suggest that the reported complication rates are accurate even with the rapid growth in the number of physicians performing these procedures.

Are These Procedures Done Too Often?

There remains some concern about the need for some of these procedures in the first place. Dr. Dore notes that while studies report that 60% to 90% of patients are pain free within 24 hours, at six weeks, six months, and one year, there are no differences seen in quality of life between those getting one of the procedures and those treated conservatively.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Joint SurgeryOsteoporosisPainTreatmentvertebral fracture

Related Articles

    Case Report: Rheumatoid Arthritis Complicated by Large Granular Lymphocytic Leukemia

    November 14, 2021

    Large granular lymphocytic (LGL) leukemia is a rare, chronic, lymphoproliferative disorder of cytotoxic T cell or natural killer cell lineage with an annual incidence of 0.72 cases per 1 million people in the U.S.1 The most common sub­type of LGL leukemia, T-LGL leukemia, follows an indolent disease course and accounts for approximately 85% of cases….

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Targeted Vertebral Fracture Assessment

    September 7, 2020

    A Canadian study sought to identify individuals at high fracture risk and provide them with pharmacotherapy to prevent fractures. They found the assessment of hip and lumbar dual-energy X-ray absorptiometry scans for vertebral fracture can be useful in the identification of women and men aged 70 years and older who should qualify for anti-osteoporosis treatment…

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences